NCT05784363View on ClinicalTrials.gov

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

June 17, 2024

Study Completion Date

July 31, 2024

Conditions
Enlarged PoresSebum Production
Interventions
DRUG

NT 201

Clostridium Botulinum neurotoxin Type A free from complexing proteins. Solution for injection prepared by reconstitution of powder with 0.9 percent (%) Sodium Chloride (NaCl).

DRUG

Placebo

Solution for injection prepared by reconstitution of powder with 0.9% NaCl.

Trial Locations (3)

33146

Merz Investigation Site #0010101, Coral Gables

37215

Merz Investigation Site #001097, Nashville

90017

Merz Investigation Site #0010473, Los Angeles

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY